Mario Ehlers is executive director, autoimmune clinical development at Immunocore. He has 17+ years’ experience in clinical development in immunology, with a focus on autoimmune diseases, notably type 1 diabetes, rheumatology (scleroderma, lupus, myositis, rheumatoid arthritis, and Sjogren’s) and dermatology (psoriasis, atopic dermatitis, and hidradenitis suppurativa). Prior to joining Immunocore, Mario was executive director and associate head of medicine, TA Inflammation, Boehringer Ingelheim (2019-2025), senior medical director, immunology, Eli Lilly (2016-2019), and deputy director, Clinical Trials Group, Immune Tolerance Network (2008-2016). Experience prior to 2008 included periods in biotech and academia. Mario holds an MBChB (MD equivalent) and a PhD from the University of Cape Town, South Africa, and completed postdoctoral training at Harvard Medical School.